Scientific Focus
The Research Scholars Program in Community PrEP Implementation supports innovative research from emerging investigators embedded within community health organizations across the United States who are working to improve the implementation of PrEP into Primary Care and close data & care gaps in real-world settings.
This program aims to strengthen research capacity within Community Health Organizations (CHOs) while generating actionable evidence that addresses PrEP implementation challenges, expands access to HIV prevention and PrEP services, and improves health outcomes in populations disproportionately affected by HIV.
This program aims to:
- Empower early-career researchers on the front line who have bold ideas to expand HIV preventive healthcare & PrEP services into primary care.
- Stimulate innovation in the US health system through bold, scalable ideas that re-imagine how HIV preventive healthcare & PrEP can transform outcomes.
- Improve HIV preventive healthcare by addressing systemic barriers, particularly in underserved communities.
Requirements
Gilead Affiliated Products
- Research focused on PrEP must look broadly at PrEP and not investigate the safety, efficiacy, tolerability or cost effectiveness of one particular product, or compare products against one another.
Funding Ineligibility
Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap in funding.
Gilead Internal Validation
The Research Scholars Program is intended to support independent research by emerging investigators that is unrelated to Gilead’s strategies or priorities. However, all research projects selected by the Scientific Review Committee will need to be approved by an internal validation committee that, in rare circumstances, may be unable to support certain clinical interventional studies (e.g., studies focused solely on the safety and/or efficacy of non-Gilead products).
Proposal Review
Proposals are reviewed by an independent Scientific Review Committee, (no Commercial involvement in review or selection, i.e., Marketing, Sales, and Commercial Strategy), and are reviewed based upon the criteria outlined on this website.
Top FAQs
The award is an industry sponsored award funded by Gilead Sciences, Inc. which is a for profit entity, not the Gilead Foundation. While the award is funded by Gilead Sciences, Inc., the review of the applications and selection of awardees is carried out by an independent scientific review committee. Gilead is not part of the scientific review committee and has no involvement in selecting the applications that receive the awards.
The approximate protected time refers to time spent on research in general. This time does not need to be spent only on research related to your RSP proposal.
